Article: Methods behind neoantigen prediction for personalized anticancer vaccines.
2023 Volume 183, Page(s) 161–186
Abstract: Next to conventional cancer therapies, immunotherapies such as immune checkpoint inhibitors have broadened the cancer treatment landscape over the past decades. Recent advances in next generation sequencing and bioinformatics technologies have made it ... ...
Abstract | Next to conventional cancer therapies, immunotherapies such as immune checkpoint inhibitors have broadened the cancer treatment landscape over the past decades. Recent advances in next generation sequencing and bioinformatics technologies have made it possible to identify a patient's own immunogenic neoantigens. These cancer neoantigens serve as important targets for personalized immunotherapy which has the benefit of being more active and effective in targeting cancer cells. This paper is a step-by-step guide discussing the different analyses and challenges encountered during in-silico neoantigen prediction. The protocol describes all the tools and steps required for the identification of immunogenic neoantigens. |
---|---|
MeSH term(s) | Humans ; Antigens, Neoplasm/genetics ; Cancer Vaccines/genetics ; Cancer Vaccines/therapeutic use ; Neoplasms/genetics ; Neoplasms/therapy ; Computational Biology ; Immunotherapy/methods |
Chemical Substances | Antigens, Neoplasm ; Cancer Vaccines |
Language | English |
Publishing date | 2023-09-11 |
Publishing country | United States |
Document type | Journal Article |
ISSN | 0091-679X |
ISSN | 0091-679X |
DOI | 10.1016/bs.mcb.2023.05.002 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.